Vergoeding 2014-2018 voor ATC-subgroep J05AF : Nucleoside en nucleotide reverse-transcriptaseremmers
- Raming voor de totale Zvw-populatie
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| J05AF01 Zidovudine (Retrovir ®) | 76.529 | 54.545 | 47.977 | 43.341 | 33.182 |
| J05AF02 Didanosine (Videx ®) | 131.650 | 86.910 | 72.288 | 38.300 | 648 |
| J05AF04 Stavudine (Zerit ®) | 5.904 | 5.089 | 4.863 | 905 | . |
| J05AF05 Lamivudine (Epivir ®) | 1.086.700 | 825.310 | 723.910 | 592.750 | 525.760 |
| J05AF06 Abacavir (Ziagen ®) | 677.290 | 644.640 | 653.630 | 585.930 | 507.490 |
| J05AF07 Tenofovirdisoproxil (Viread ®) | 6.783.600 | 6.926.200 | 6.946.500 | 6.492.100 | 2.559.700 |
| J05AF08 Adefovir (Hepsera ®) | 630.270 | 529.460 | 431.190 | 377.140 | 351.560 |
| J05AF09 Emtricitabine (Emtriva ®) | 76.824 | 98.819 | 111.560 | 80.060 | 55.831 |
| J05AF10 Entecavir (Baraclude ®) | 6.257.200 | 6.453.400 | 7.099.800 | 7.479.200 | 3.441.600 |
| J05AF11 Telbivudine (Sebivo ®) | 42.474 | 33.261 | 21.624 | 22.045 | 24.703 |
| J05AF13 Tenofoviralafenamide (Vemlidy ®) | . | . | . | 58.458 | 522.440 |
| Totaal | 15.768.441 | 15.657.634 | 16.113.342 | 15.770.229 | 8.022.914 |